Flexion Therapeutics Inc. (NASDAQ:FLXN) went down by -0.84% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Drug Manufacturers – Specialty & Generic giant went up by $13.04 to trade ended Wednesday trading at $13.15. This is down from the $13.15 price recorded on Tuesday’s trading session. Thanks to this latest performance, FLXN is closer to the higher price 52-week target of $35.00 and further from the lowest price target of $17.00. Its performance from the start of the year has also been negative, with FLXN down by -37.00% year-to-date.
Flexion Therapeutics Inc. (FLXN) started the day trading at $13.2 and recorded an intraday high of $13.57. It also recorded an intraday low of $12.78 during Wednesday’s trading session. Flexion Therapeutics Inc. is a very active stock that recorded a trading volume that is less than -86.3% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 507019, which is less than -86.3 of the total average daily trading volume of 944.56K.
Flexion Therapeutics Inc. (NASDAQ:FLXN) 2020 Performance Impressive
The increase in FLXN’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of FLXN currently stands at $22.98, which is higher than the current trading price of the stock by 43.26%. However, FLXN’s current trading price is -160.28% lower than the 52-week low price of $5.01. In terms of trading volume, Flexion Therapeutics Inc. currently experienced healthy participation during the last trading session. 507019 shares of Flexion Therapeutics Inc. were traded on the stock exchange on Wednesday, which is less than -86.3% of the 944.56K average trading volume of the stock.
The performance of the stock has been positive over the past year. FLXN’s performance over the past one year has seen it surge by 13.29%, while the stock has gone down by -37.00% in the last six months. The quarterly performance of FLXN currently stands at 86.02%, and it is up by 7.06% in the last month. The only positive figure was from the weekly performance, which currently reads 7.86%. At the time of writing FLXN’s report, the company has a total market cap of $644.05M, making it one of the largest publicly-traded companies in the world.Flexion Therapeutics Inc. also has over 288 employees all over the world.
FLXN Insider Activities
For Flexion Therapeutics Inc., insiders hold 78.00% of all company shares. The insider transactions over the past six months are up by 48.70%. During that period, insiders bought 264,400 shares in 20 transactions. In that same period, insiders sold 37,907 of their shares in 11 transactions. After these transactions, insiders at Flexion Therapeutics Inc. now hold 812.9k shares, which is over 96.50% of the total company stocks. Institutional investors currently hold a large chunk of the FLXN shares, as they control 2.11% of the company’s total stock.
FLXN Fundamental Analysis
For Flexion Therapeutics Inc., the stock’s diluted earnings per share (EPS) stands at -3.79. In the coming year, analysts expect the EPS to be -1.60. The EPS growth will up over the next five years to 20.00% after plunging by -14.90% in the previous five years. In terms of revenue, Flexion Therapeutics Inc.’s quarterly sales (YOY) is shrinking at -0.80, which is higher than the average annual revenue of -14.90% over the past half a decade.
The Return on Investment (ROI) on Flexion Therapeutics Inc.’s stock currently stands at -78.50%. The gross margin of the company is 87.30%.
FLXN Analysts Prediction
Another analyst that has a Buy rating for FLXN is The Benchmark Company, which set a price target of between $19 and $25.
BTIG Research and Needham also believe that Flexion Therapeutics Inc.’s stock is outperforming at the moment. FLXN received a positive rating from Needham, which set a price target of $42-$36 for the stock.
FLXN Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of FLXN currently stands at 5.59%, while the SMA50 is 18.79%. The biggest one is the SMA200, which is currently reading -7.74% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 57.66.